Results 121 to 130 of about 60,444 (298)

Sodium Glycididazole Combined with Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Multicenter Randomized Clinical Trial

Precision Radiation Oncology, EarlyView.
• To evaluate the efficacy and safety of a radiosensitizer: sodium glycididazole (CMNa) combined with definitive concurrent chemoradiotherapy (CCRT). • CMNa plus CCRT improved the ORR of patients compared with CCRT alone without causing significant side effects. OPN might be a predictor of the benefit of ORR of CMNa.
Xiaoling Li, Hanxi Zhao, Peng Xie, Wanqi Zhu, Liping Liu, Peipei Wu, Yanxing Sheng, Chuandong Wang, Yipeng Song, Xiangjiao Meng, Jiandong Zhang, Ligang Xing   +11 more
wiley   +1 more source

Research progress on moxibustion for relieving chemotherapy-induced adverse drug reactions in cancer patients (艾灸缓解肿瘤化疗相关不良反应的研究进展)

中西医结合护理
Adverse drug reactions have a direct impact on the treatment effect and quality of life of patients with malignant tumors. Research has found that moxibustion can effectively relieve the chemotherapy-induced adverse drug reactions.
YA Liu (严柳), GAO Yaqian (高雅倩)
doaj   +1 more source

Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide

Journal of Ginseng Research, 2018
Background Ginsenoside Re (Re) is one of the major components of Panax ginseng Meyer. Ginsenoside Rk3 (Rk3) is a secondary metabolite of Re. The aim of this study was to investigate and compare the effects and underlying mechanisms of Re and Rk3 on ...
Jiahong Han, Jing Xia, Lianxue Zhang, Enbo Cai, Yan Zhao, Xuan Fei, Xiaohuan Jia, He Yang, Shuangli Liu   +8 more
semanticscholar   +1 more source

Construction and validation of a predictive model for the risk of myelosuppression after first-line chemotherapy in patients with advanced colorectal cancer [PDF]

Yixue xinzhi zazhi
Objective To investigate the risk factors influencing the incidence of chemotherapy-induced myelosuppression (CIM) following first-line chemotherapy in patients with moderately advanced colorectal cancer (CRC), and to develop and validate a nomogram to ...
WANG Xuexing, ZHANG Rong, CHU Jie, LIU Zhijin   +3 more
doaj   +1 more source

Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan

Acta Pharmaceutica Sinica B, 2018
Pharmacometabolomics has been already successfully used in toxicity prediction for one specific adverse effect. However in clinical practice, two or more different toxicities are always accompanied with each other, which puts forward new challenges for ...
Yi-qiao Gao, Wei Li, Jiaqing Chen, Xu Wang, Yingtong Lv, Yin Huang, Zunjian Zhang, Fengguo Xu   +7 more
semanticscholar   +1 more source

Individualized T3‐4N+ Rectal Cancer Treatment Strategies: Exploring the Efficacy of Preoperative Synchronized Lateral Lymph Node Simultaneous Integrated Boost Radiation Therapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Anatomical Diagram: It shows a cross‐section of the pelvic area highlighting the rectum and lateral lymph nodes, which are the focal points of the treatment strategy discussed in the paper. Flowchart: It outlines the treatment process from preoperative synchronized radiation therapy to the subsequent surgical procedures, illustrating the sequence of ...
Xinjue Shi, Siyao Zhong, Xianbin Zheng, Xianxiu Nan, Xuan Liu, Qiteng Liu, Jing Yuan, Yuyan Gao   +7 more
wiley   +1 more source

Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia

PLoS ONE, 2019
We investigate the personalisation and prediction accuracy of mathematical models for white blood cell (WBC) count dynamics during consolidation treatment using intermediate or high-dose cytarabine (Ara-C) in acute myeloid leukaemia (AML).
Felix Jost, E. Schalk, Kristine Rinke, T. Fischer, S. Sager   +4 more
semanticscholar   +1 more source

Management of Advanced Prostate Cancer in the Asia‐Pacific Region: Summary of the Asia‐Pacific Advanced Prostate Cancer Symposium 2025

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Summary of the Asia Pacific Advanced Prostate Cancer Symposium 2025, showing disciplines and diversity of participants, discussion topics (high‐risk localized/locally advanced prostate cancer; PSA persistence and recurrence; radioligand therapy; genetics and genomics; bone protection and other aspects of supportive care), key themes, and high‐level ...
Edmund Chiong, Renu Eapen, Nicholas Buchan, Kenneth Chen, Lukman Hakim, Agus Rizal Hamid, Jae‐Young Joung, Ravindran Kanesvaran, Makarand Khochikar, Jason Letran, Bannakij Lojanapiwat, Indranil Mallick, Chi Fai Ng, Pei Ing Ngam, Teng Aik Ong, Jacob Pang, Darren M. C. Poon, Natasha Roberts, Marniza Saad, Shinichi Sakamoto, Jeremy Tey, Sue Ping Thang, Poh Choo Toh, Levent Türkeri, Nguyễn Tuấn Vinh, Alvin Wong, Yao Zhu, ANZUP Cancer Trials Group, Ian D. Davis   +28 more
wiley   +1 more source

Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels – A Strategy for Brain Cancer Treatments [PDF]

, 2016
Purpose The blood brain barrier compromises glioblastoma chemotherapy. However high blood concentrations of lipophilic, alkylating drugs result in brain uptake, but cause myelosuppression.
Benattayallah, A, Chooi, KW, Fisusi, FA, Garrett, N, Lalatsa, K, Moger, I, Okubanjo, O, Satchi-Fainaro, R, Schatzlein, AG, Siew, A, Stapleton, P, Summers, I, Uchegbu, IF   +12 more
core  

Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression

Scientific Reports, 2017
Carboplatin, a second-generation platinum agent, has been used as a cancer therapy for decades and exhibits strong anti-tumor activity. However, the wide application of carboplatin is largely limited due to its side effects, especially myelosuppression ...
Xiao Chen, Jigang Wang, Zhongping Fu, Bo Zhu, Jie Wang, Shengwen Guan, Z. Hua   +6 more
semanticscholar   +1 more source